Kurs
+11,29%
Kurs
+11,29%
Open
23,74
High
28,30
Low
23,55
Close
26,21
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
Est. tid* | ||
2026-06-24 | N/A | Årsstämma |
2026-03-05 | 06:10 | Bokslutskommuniké 2025 |
2025-11-26 | 06:10 | Kvartalsrapport 2025-Q3 |
2025-09-17 | 06:10 | Kvartalsrapport 2025-Q2 |
2025-06-26 | N/A | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2025-06-25 | N/A | Årsstämma |
2025-06-10 | 06:10 | Kvartalsrapport 2025-Q1 |
2025-03-26 | - | Bokslutskommuniké 2024 |
2024-12-20 | - | Extra Bolagsstämma 2024 |
2024-11-27 | - | Kvartalsrapport 2024-Q3 |
2024-09-12 | - | Kvartalsrapport 2024-Q2 |
2024-06-28 | - | Kvartalsrapport 2024-Q1 |
2024-06-27 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2024-06-26 | - | Årsstämma |
2024-03-20 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-09-26 | - | Kvartalsrapport 2023-Q2 |
2023-06-21 | - | Årsstämma |
2023-06-21 | - | Kvartalsrapport 2023-Q1 |
2023-03-30 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-12-09 | - | Extra Bolagsstämma 2022 |
2022-10-26 | - | Kvartalsrapport 2022-Q3 |
2022-08-15 | - | Kvartalsrapport 2022-Q2 |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-04-19 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2022-04-17 | - | Årsstämma |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-12-29 | - | Extra Bolagsstämma 2021 |
2021-11-17 | - | Kvartalsrapport 2021-Q3 |
2021-09-08 | - | Kvartalsrapport 2021-Q2 |
2021-04-29 | - | Kvartalsrapport 2021-Q1 |
2021-04-14 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2021-04-13 | - | Årsstämma |
2021-02-09 | - | Bokslutskommuniké 2020 |
2020-12-14 | - | Kvartalsrapport 2020-Q3 |
2020-09-30 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2020-06-30 | - | Årsstämma |
2020-06-30 | - | Kvartalsrapport 2020-Q1 |
2019-12-20 | - | Extra Bolagsstämma 2019 |
2019-06-27 | - | Årsstämma |
2019-06-03 | - | X-dag ordinarie utdelning SOFTX 0.00 NOK |
2018-07-02 | - | Split SOFTX 1:50 |
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2020-11-03 10:04:07
Oslo 03.11.2020 The project is a research and development collaboration between SoftOx Solutions AS and leading US and European wound care clinics, focusing on chronic wounds and biofilm infections. The project represents an innovative treatment principle in how to prevent and treat biofilm infections in wounds. The grant will contribute to perform clinical investigations to evaluate the SoftOx technology in humans with serious non-healing wounds. The award was issued on behalf of the Naval Medical Research Center (NMRC) under Medical Technology Enterprise Consortium (MTEC) a biomedical technology consortium that collaborates under a transaction agreement (OTA) with the US Army Medical Research and Development Command (USAMRDC). The award issued is entitled “Clinical Development of a New Antimicrobial Agent to Treat and Prevent Biofilm Formation in Wounds”. SoftOx considers it a great honor that one of the world’s leading research organizations supports the development and the technology of SoftOx by issuing the award. About SoftOx Solutions SoftOx Solutions AS (SoftOx, listed at Oslo Stock Exchange Merkur Market) is a Norwegian MedTech company based in Oslo with the aim to contribute to fight major threats to human health, namely; the Emergence of Antimicrobial Resistance (AMR), Biofilm Infections in Chronic Wounds and Spread of viruses. For more information about SoftOx please visit www.soft-ox.com About Medical Technology Enterprise Consortium MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transactional Agreement with the U.S. Army Medical Research and Development Command. To find out more about MTEC, visit www.mtec-sc.org.